Advertisement
 
YOU ARE HERE: LAT HomeCollectionsSanten Pharmaceutical
IN THE NEWS

Santen Pharmaceutical

FEATURED ARTICLES
ARTICLES BY DATE
BUSINESS
September 1, 2000 | Dow Jones
Irvine eye-care company Allergan Inc. has filed a federal lawsuit against a pharmaceutical company, alleging the company has infringed on Allergan's rights under a license to use another firm's patent. Santen Pharmaceutical Co. said in a press release Thursday that it will "vigorously" defend itself and its subsidiary, Santen Inc., against Allergan's claims.
Advertisement
BUSINESS
September 1, 2000 | Dow Jones
Irvine eye-care company Allergan Inc. has filed a federal lawsuit against a pharmaceutical company, alleging the company has infringed on Allergan's rights under a license to use another firm's patent. Santen Pharmaceutical Co. said in a press release Thursday that it will "vigorously" defend itself and its subsidiary, Santen Inc., against Allergan's claims.
BUSINESS
July 15, 2012
About the fund Co-manager: David Nadel The fund: Royce Global Value Fund (RIVFX) Headquarters: New York Assets: About $300 million Top five holdings : Semperit AG Holding (Austria), Jupiter Fund Management (United Kingdom), Santen Pharmaceutical (Japan), Mayr-Melnhof Karton (Austria), Value Partners Group (Hong Kong) Morningstar rating : Three stars Performance: Annualized three-year return of 13%
BUSINESS
May 30, 1996
Allergan Inc. said it has received approval from the Food and Drug Administration to market Ocuflox 0.3% for the treatment of corneal ulcers. Allergan said the ophthalmic solution is already indicated for the treatment of bacterial conjunctivitis. The company, which develops, manufactures and markets specialty therapeutic products for eye and skin care and neuromuscular disorders, licenses Ocuflox from Daiichi Pharmaceutical Co., in Tokyo, and Santen Pharmaceutical Co., in Osaka, Japan.
BUSINESS
July 8, 1998 | Dow Jones
Allergan Inc.'s second-quarter revenue was stronger than expected, primarily because of continued growth in sales of its Alphagan and Botox drugs as well as strong sales of other pharmaceutical products to U.S. wholesalers, the Irvine company said Tuesday. Revenue totaled $284.5 million in the second quarter last year. Allergan also said it signed agreements granting Japan's Santen Pharmaceutical Co. exclusive distribution rights for Alphagan in that country.
BUSINESS
July 9, 1998 | From Times Wire Services
Stocks surged at the expense of bond prices Wednesday as investors bought shares in big companies amid optimism about quarterly earnings. The dollar rose against the Japanese yen as dealers were disappointed with Japan's pledge to stimulate its economy through permanent tax reforms. The Dow Jones industrial average closed up 89.93 points, a gain of almost 1%, at 9,174.97.
BUSINESS
July 9, 1998 | From Times Staff and Wire Reports
Another rally in big-name stocks drove key U.S. indexes to record highs Wednesday, while the broader market rose more modestly in average trading. Today, recently red-hot Internet-related stocks may be poised to rocket again, after a stronger-than-expected earnings report from Internet search vehicle Yahoo late Wednesday. On Wall Street, the Nasdaq composite index rose 27.28 points, or 1.4%, to a record 1,935.39 on Wednesday, the first record close since April 22.
BUSINESS
September 27, 2000 | MARK MAGNIER, TIMES STAFF WRITER
The Bridgestone tire scandal isn't the half of it. A series of defects, product recalls, poisonings and quality lapses at some of Japan's best-known companies in recent months are outward signs of a seismic shift taking place deep within the economy. Hanging in the balance is Japan's ability to compete effectively in the 21st century.
BUSINESS
September 26, 1994 | PATRICK LEE, TIMES STAFF WRITER
Despite recent headlines concerning Commerce Secretary Ronald H. Brown's trade mission to China and impending U.S. economic sanctions against Japan, even a casual perusal of recent news out of the Asia-Pacific region shows that a lot of business there has little or nothing to do with the West. Indeed, analysts say, Asian nations are looking more to themselves--and one another--for new trade ties, economic development and new wealth.
Los Angeles Times Articles
|